Uprifosbuvir
Uprifosbuvir is an antiviral agent. Uprifosbuvir is a NS5b inhibitor developed for the research of chronic hepatitis C virus[1].
Product Specifications
CAS Number
[1496551-77-9]
Product Name Alternative
IDX21437; MK-3682
UNSPSC
12352005
Target
HCV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/uprifosbuvir.html
Purity
99.20
Solubility
DMSO : 250 mg/mL (ultrasonic)
Smiles
C[C@]([C@@](N(C=CC1=O)C(N1)=O)([H])O[C@@H]2CO[P@@](OC3=CC=CC=C3)(N[C@H](C)C(OC(C)C)=O)=O)([C@@H]2O)Cl
Molecular Formula
C22H29ClN3O9P
Molecular Weight
545.91
References & Citations
[1]Klapars A, et al. Efficient synthesis of antiviral agent uprifosbuvir enabled by new synthetic methods. Chem Sci. 2021;12 (26) :9031-9036.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
138372-Biotin 100 µL
SLC36A3 (Proton-coupled Amino Acid Transporter 3, Proton/Amino Acid Transporter 3, Solute Carrier Family 36 Member 3, Tramdorin-2, PAT3, TRAMD2, FLJ16658, MGC119638, MGC119639, MGC119641) (Biotin)
Ask
View Details 
MBS1344126-01 0.5 mg (E-Coli)
Recombinant Bos indicus ATP synthase protein 8 (MT-ATP8), partial
Ask
View Details MBS1344126-02 0.05 mg (Baculovirus)
Recombinant Bos indicus ATP synthase protein 8 (MT-ATP8), partial
Ask
View Details 
MBS1344126-03 0.5 mg (Yeast)
Recombinant Bos indicus ATP synthase protein 8 (MT-ATP8), partial
Ask
View Details